TEVATeva Pharmaceutical Industries Ltd · Insider ownership research

Teva Pharmaceutical Industries Ltd insiders sold $113M in the past 12 months. How much of their stake is that?

Insiders sold $113M in the past 12 months.61% was sold under disclosed trading plans, 39% with no plan disclosed. The largest seller, Richard Francis (President and CEO), sold $31.3M.Share-of-stake figures for this company are being verified and will be added when that check is finished. Why

Updated Oct 13, 2026 from SEC filings · covers Oct 14, 2025 to Oct 13, 2026

$43.9M

sold with no plan disclosed, past 12 months

61%

of sales were under disclosed trading plans, past 12 months

14 of 24

officers and directors sold shares, past 12 months

Is this normal? More than usual: about 4x the 5-year average. 14 insiders sold; the average is 8 a year. Year by year

Latest filing: Filed Sep 22 for a sale on Sep 18. Roberto Mignone sold 368K shares ($14.4M) with no plan disclosed. Filing

SEC ownership filings: 84 filed in the 12 months to Oct 13, 2026; 651 on record since Jan 2, 2018 · See the evidence

What stands out

Five insiders sold $43.3M with no disclosed plan: Roberto Mignone ($22.8M), Mark Sabag ($13.1M) and Richard Daniell ($4.4M), plus 2 more. The filings don't state a reason.Roberto Mignone: largest such sale, Sep 18, 2026 · Mark Sabag: largest such sale, May 1, 2026 · Richard Daniell: largest such sale, Dec 9, 2025

A share of stake is shown for 0 of the 14 officers and directors who sold. 24 are left out

i

Left out: Amir Elstein, Roberto Mignone, Sol Barer, Eliyahu Kalif, Richard Francis, Mark Sabag, Gerald Lieberman, Rosemary Crane, Perry Nisen, Ronit Satchi-Fainaro, Janet Vergis, Tal Zaks, Christine Fox, Richard Daniell, Amir Weiss, Varda Shalev, David McAvoy, Dov Bergwerk, Matthew Shields, Placid Jover, Brian Savage, Eric Hughes, Chen Lichtenstein and Evan Lippman (share of stake is being verified).

Disclosed company stock is not an insider's whole wealth.

Who sold, and how much of their stake

Officers and directors, past 12 months. Their share of stake is being verified and is not shown yet; amounts and trading plans are below.

Richard Francis

President and CEO

Not confirmed

Share of stake not shown: share of stake is being verified. Why

$31.3MDisclosed plan

Roberto Mignone

Director

Not confirmed

Share of stake not shown: share of stake is being verified. Why

$22.8MNo plan disclosed

Eliyahu Kalif

EVP, Chief Financial Officer

Not confirmed

Share of stake not shown: share of stake is being verified. Why

$20.7MDisclosed plan

Mark Sabag

Executive Vice President, International Markets Commercial

Not confirmed

Share of stake not shown: share of stake is being verified. Why

$13.1MNo plan disclosed

Richard Daniell

EVP, Europe Commercial

Not confirmed

Share of stake not shown: share of stake is being verified. Why

$12.1M64% planned 36% no plan disclosed

Selling by month

Officers and directors, Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planTo cover taxesNo plan disclosedOne dollar scale for every month; the tallest bar is labeled

Recent activity

Past 30 days, Sep 14, 2026 to Oct 13, 2026

Sep 18, 20262 insiders sold 375K shares ($14.6M) with no plan disclosed. 4.5K shares came in from vesting or option exercises the same day, so their combined holdings fell by 370K net.

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Roberto Mignone Director	367,600	$39.06	n/a	n/a	Sep 18, 2026	Sep 22, 2026
Brian Savage Interim Chief Legal Officer	7,342	$38.85	n/a	n/a	Sep 18, 2026	Sep 22, 2026

"% of total stake" is the shares in an event against all the vested shares the person held that day, across every share class and holding entity, after that day's vesting. "n/a" means the person's holdings are not confirmed, or the row is a purchase. "Holdings record incomplete" means more shares were sold than the filings show the person held that day, so a percentage would be wrong.

Common questions

Is the Teva Pharmaceutical Industries Ltd CEO selling stock?

Yes. Richard Francis sold 940K shares ($31.3M) in the past 12 months, all of it under a trading plan disclosed in the filings.

Why are Teva Pharmaceutical Industries Ltd insiders selling?

Filings rarely give a reason, and we don't guess at one. What they show is how the sales were made: 61% of sales by value ran under 10b5-1 trading plans disclosed in the filings, 0.1% were to cover taxes and 39% had no disclosed plan. A trading plan schedules sales in advance.

Are any Teva Pharmaceutical Industries Ltd insiders buying?

No. Officers and directors reported no purchases in the past 12 months.

The evidence

Who sold14 officers and directors: amount, % of holdings, trading plan

Who sold	Amount	% of holdings	Trading plan
Richard Francis President and CEO	$31.3M 940K shares	Not confirmed share of stake is being verified. Why	Disclosed plan
Roberto Mignone Director	$22.8M 695K shares	Not confirmed share of stake is being verified. Why	No plan disclosed
Eliyahu Kalif EVP, Chief Financial Officer	$20.7M 606K shares	Not confirmed share of stake is being verified. Why	Disclosed plan
Mark Sabag Executive Vice President, International Markets Commercial	$13.1M 423K shares	Not confirmed share of stake is being verified. Why	No plan disclosed
Richard Daniell EVP, Europe Commercial	$12.1M 383K shares	Not confirmed share of stake is being verified. Why	64% under a disclosed plan 36% no plan disclosed
Eric Hughes Executive Vice President, Global R&D and Chief Medical Officer	$4.2M 127K shares	Not confirmed share of stake is being verified. Why	Disclosed plan
Christine Fox EVP, U.S. Commercial	$2.7M 97K shares	Not confirmed share of stake is being verified. Why	45% under a disclosed plan 55% no plan disclosed
Evan Lippman EVP, Business Development	$2.2M 60K shares	Not confirmed share of stake is being verified. Why	Disclosed plan
Amir Weiss Chief Accounting Officer	$1.4M 45K shares	Not confirmed share of stake is being verified. Why	No plan disclosed
Matthew Shields EVP, Global Operations	$1.4M 43K shares	Not confirmed share of stake is being verified. Why	77% under a disclosed plan 23% no plan disclosed
Placid Jover Executive Vice President, Chief Human Resources Officer	$895K 27K shares	Not confirmed share of stake is being verified. Why	Disclosed plan
Brian Savage Interim Chief Legal Officer	$449K 12K shares	Not confirmed share of stake is being verified. Why	36% to cover taxes 64% no plan disclosed
Ronit Satchi-Fainaro Director	$15K 415 shares	Not confirmed share of stake is being verified. Why	No plan disclosed
Tal Zaks Director	$593 17 shares	Not confirmed share of stake is being verified. Why	No plan disclosed

The full ownership picture0 of 24 officers and directors confirmed

Vested shares across all share classes, held directly and through trusts, LLCs and family members, as reported on SEC Forms 3, 4 and 5. Unvested awards and options are never counted as owned shares.

Insider

Held Oct 13, 2025

Sold

Held Oct 13, 2026

Still held

Amir Elstein

!

Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Amir Elstein are complete.

Director

n/a

0

n/a

n/a

Vesting, gifts, unvested awards and holding lines for Amir Elstein

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Amir Elstein are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Roberto Mignone

!

Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Roberto Mignone are complete.

Director

n/a

−695K

n/a

n/a

Vesting, gifts, unvested awards and holding lines for Roberto Mignone

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Roberto Mignone are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Sol Barer

!

Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Sol Barer are complete.

Director

n/a

0

n/a

n/a

Vesting, gifts, unvested awards and holding lines for Sol Barer

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Sol Barer are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Eliyahu Kalif

!

Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Eliyahu Kalif are complete.

EVP, Chief Financial Officer

n/a

−606K

n/a

n/a

Vesting, gifts, unvested awards and holding lines for Eliyahu Kalif

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Eliyahu Kalif are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Richard Francis

!

Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Richard Francis are complete.

President and CEO

n/a

−940K

n/a

n/a

Vesting, gifts, unvested awards and holding lines for Richard Francis

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Richard Francis are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Mark Sabag

!

Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Mark Sabag are complete.

Executive Vice President, International Markets Commercial

n/a

−423K

n/a

n/a

Vesting, gifts, unvested awards and holding lines for Mark Sabag

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Mark Sabag are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Gerald Lieberman

!

Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Gerald Lieberman are complete.

Director

n/a

0

n/a

n/a

Vesting, gifts, unvested awards and holding lines for Gerald Lieberman

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Gerald Lieberman are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Rosemary Crane

!

Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Rosemary Crane are complete.

Director

n/a

0

n/a

n/a

Vesting, gifts, unvested awards and holding lines for Rosemary Crane

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Rosemary Crane are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Perry Nisen

!

Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Perry Nisen are complete.

Director

n/a

0

n/a

n/a

Vesting, gifts, unvested awards and holding lines for Perry Nisen

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Perry Nisen are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Ronit Satchi-Fainaro

!

Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Ronit Satchi-Fainaro are complete.

Director

n/a

−415

n/a

n/a

Vesting, gifts, unvested awards and holding lines for Ronit Satchi-Fainaro

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Ronit Satchi-Fainaro are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Janet Vergis

!

Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Janet Vergis are complete.

Director

n/a

0

n/a

n/a

Vesting, gifts, unvested awards and holding lines for Janet Vergis

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Janet Vergis are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Tal Zaks

!

Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Tal Zaks are complete.

Director

n/a

−17

n/a

n/a

Vesting, gifts, unvested awards and holding lines for Tal Zaks

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Tal Zaks are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Christine Fox

!

Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Christine Fox are complete.

EVP, U.S. Commercial

n/a

−97K

n/a

n/a

Vesting, gifts, unvested awards and holding lines for Christine Fox

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Christine Fox are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Richard Daniell

!

Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Richard Daniell are complete.

EVP, Europe Commercial

n/a

−383K

n/a

n/a

Vesting, gifts, unvested awards and holding lines for Richard Daniell

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Richard Daniell are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Some sales match sales reported by Matthew Shields exactly (date, shares and price). Possibly the same shares reported by both; the filings don't confirm it.

Amir Weiss

!

Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Amir Weiss are complete.

Chief Accounting Officer

n/a

−45K

n/a

n/a

Vesting, gifts, unvested awards and holding lines for Amir Weiss

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Amir Weiss are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
7,502	$19.16	Mar 2, 2028	$147K

Estimate: options held × ($38.70 − strike price), using the most recent insider trade price on Form 4 (Sep 18, 2026), not a market close.

Varda Shalev

!

Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Varda Shalev are complete.

Director

n/a

0

n/a

n/a

Vesting, gifts, unvested awards and holding lines for Varda Shalev

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Varda Shalev are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

David McAvoy

!

Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for David McAvoy are complete.

EVP, Chief Legal Officer

n/a

0

n/a

n/a

Vesting, gifts, unvested awards and holding lines for David McAvoy

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for David McAvoy are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Dov Bergwerk

!

Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Dov Bergwerk are complete.

Interim Cheif Legal Officer

n/a

0

n/a

n/a

Vesting, gifts, unvested awards and holding lines for Dov Bergwerk

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Dov Bergwerk are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
17,505	$34.70	Mar 3, 2027	$70K
8,755	$28.98	May 24, 2027	$85K

Estimate: options held × ($38.70 − strike price), using the most recent insider trade price on Form 4 (Sep 18, 2026), not a market close.

Matthew Shields

!

Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Matthew Shields are complete.

EVP, Global Operations

n/a

−43K

n/a

n/a

Vesting, gifts, unvested awards and holding lines for Matthew Shields

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Matthew Shields are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Some sales match sales reported by Richard Daniell exactly (date, shares and price). Possibly the same shares reported by both; the filings don't confirm it.

Placid Jover

!

Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Placid Jover are complete.

Executive Vice President, Chief Human Resources Officer

n/a

−27K

n/a

n/a

Vesting, gifts, unvested awards and holding lines for Placid Jover

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Placid Jover are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Brian Savage

!

Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. See the filing Sales and other transactions for Brian Savage are complete.

Interim Chief Legal Officer

n/a

−12K

n/a

n/a

Vesting, gifts, unvested awards and holding lines for Brian Savage

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Brian Savage are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
2,253	$53.50	Mar 17, 2026	$0

Estimate: options held × ($38.70 − strike price), using the most recent insider trade price on Form 4 (Sep 18, 2026), not a market close.

Eric Hughes

!

Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Eric Hughes are complete.

Executive Vice President, Global R&D and Chief Medical Officer

n/a

−127K

n/a

n/a

Vesting, gifts, unvested awards and holding lines for Eric Hughes

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Eric Hughes are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Chen Lichtenstein

!

Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Chen Lichtenstein are complete.

Director

n/a

0

n/a

n/a

Vesting, gifts, unvested awards and holding lines for Chen Lichtenstein

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Chen Lichtenstein are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Evan Lippman

!

Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Evan Lippman are complete.

EVP, Business Development

n/a

−60K

n/a

n/a

Vesting, gifts, unvested awards and holding lines for Evan Lippman

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Evan Lippman are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Holdings and share of stake for Teva Pharmaceutical Industries Ltd are being verified, so no balances, unit counts or percentages are shown. Sales, proceeds, plan and tax status, titles and dates come straight from individual filings.

What explains the selling$113M of sales by plan status, purpose, seller and month

Officer and director open-market sales: $113M across 3,459,122 shares. Plan status and stated purpose are separate questions, and a sale can have both.

By plan status

Disclosed plan · $69.3M · 61%

39%

The lighter segment is sales with no plan disclosed in the filing ($44.0M), including tax-related sales outside a plan.

No plan disclosed · $43.9M

Sales with no 10b5-1 plan and no tax reference in the filing. $22.8M of it is Roberto Mignone. No plan disclosed is a statement about the filing, not about why the sale happened. Largest such sale: Roberto Mignone, Sep 18, 2026

Taxes

$46.8M of sales (41.3%) cite tax obligations in their footnotes, $46.6M of them also under a plan. Example: Eric Hughes, Aug 3, 2026

Seller	Shares sold	Proceeds	Under a disclosed plan	Share of total	Sales dates
Richard Francis President and CEO	940K	$31.3M	100%	28%	Feb 15, 2026 to Jun 5, 2026
Roberto Mignone Director	695K	$22.8M	0%	20%	Nov 6, 2025 to Sep 18, 2026
Eliyahu Kalif EVP, Chief Financial Officer	606K	$20.7M	100%	18%	Feb 26, 2026 to Jun 11, 2026
Mark Sabag Executive Vice President, International Markets Commercial	423K	$13.1M	0%	12%	Dec 9, 2025 to May 1, 2026
Richard Daniell EVP, Europe Commercial	383K	$12.1M	64%	11%	Dec 9, 2025 to May 5, 2026
Eric Hughes Executive Vice President, Global R&D and Chief Medical Officer	127K	$4.2M	100%	4%	Mar 3, 2026 to Aug 3, 2026
Christine Fox EVP, U.S. Commercial	97K	$2.7M	45%	2%	Nov 14, 2025 to Apr 30, 2026
Evan Lippman EVP, Business Development	60K	$2.2M	100%	2%	May 14, 2026 to Aug 17, 2026
Amir Weiss Chief Accounting Officer	45K	$1.4M	0%	1%	Nov 6, 2025 to Aug 21, 2026
Matthew Shields EVP, Global Operations	43K	$1.4M	77%	1%	Mar 5, 2026 to Jun 18, 2026
Placid Jover Executive Vice President, Chief Human Resources Officer	27K	$895K	100%	0.8%	Mar 5, 2026 to Aug 3, 2026
Brian Savage Interim Chief Legal Officer	12K	$449K	0%	0.4%	Mar 3, 2026 to Sep 18, 2026
Ronit Satchi-Fainaro Director	415	$15K	0%	0.0%	Aug 21, 2026 to Aug 21, 2026
Tal Zaks Director	17	$593	0%	0.0%	Aug 5, 2026 to Aug 5, 2026

Sales by month

Month	Sale proceeds	Disclosed plan	To cover taxes	No plan disclosed
Oct 2025	$0	$0	$0	$0
Nov 2025	$7.9M	$700K	$0	$7.2M
Dec 2025	$12.3M	$0	$0	$12.3M
Jan 2026	$0	$0	$0	$0
Feb 2026	$27.0M	$27.0M	$0	$0
Mar 2026	$30.3M	$28.3M	$164K	$1.9M
Apr 2026	$751K	$0	$0	$751K
May 2026	$13.4M	$6.9M	$0	$6.5M
Jun 2026	$4.7M	$4.4M	$0	$322K
Jul 2026	$0	$0	$0	$0
Aug 2026	$2.4M	$2.0M	$0	$371K
Sep 2026	$14.6M	$0	$0	$14.6M
Oct 2026	$0	$0	$0	$0

Is this normal? Selling year by year5 earlier years to compare with

More than usual: about 4x the 5-year average. 14 insiders sold; the average is 8 a year.

12 months ending	Shares sold	Insiders who sold	Proceeds
Oct 13, 2026 Latest 12 months	3.46M	14	$113M
Oct 13, 2025 1 year earlier	1.46M	10	$25.9M
Oct 13, 2024 2 years earlier	1.41M	10	$21.5M
Oct 14, 2023 3 years earlier	512K	7	$4.9M
Oct 14, 2022 4 years earlier	502K	7	$4.2M
Oct 14, 2021 5 years earlier	916K	8	$10.4M

Open-market sales (Form 4 code S) by people who were officers or directors, in split-adjusted shares. Earlier years include people who have since left. A sale that an outside holder also reports (a family trust, a fund) is counted with outside holders in every year. Shares, not dollars, are compared, so a change in the stock price doesn't look like a change in selling. Years the filings don't fully cover are shown but left out of the average.

Known gaps and uncertainty24 officers and directors not confirmed

Holdings and share of stake are being verified. Balances, unit counts and every share-of-stake figure for Teva Pharmaceutical Industries Ltd are held back until that check is finished. Sales, proceeds, plan and tax status, titles and dates come straight from individual filings and are complete.

External context: we only cite outside events when a documented connection exists. None is shown for this period.

Sources and methodology651 filings on record, 84 filed in the 12-month period, and how we read them

All 651 Forms 3, 4 and 5 on record for Teva Pharmaceutical Industries Ltd (SEC CIK 818686), filed from Jan 2, 2018 to Oct 8, 2026; 84 of them were filed in the 12 months this page covers, retrieved from SEC EDGAR on Oct 13, 2026. Prices are the ones reported in each filing, often weighted averages. 5 filings were left out because Teva Pharmaceutical Industries Ltd filed them as an owner of another company's stock.

Holdings. Each holding line (a share class plus an owner, such as a trust or LLC) carries its last reported balance forward. Entities first reported during the period start at zero, so transfers between an insider's own trusts don't count as selling. Lines not reported for three years or more are listed separately and left out of totals.

Sales. A sale counts as under a 10b5-1 plan if its footnote cites one or the filing's Rule 10b5-1 box is checked, and as tax-related if its footnote cites tax obligations or sell-to-cover. Shares withheld by the company for taxes are listed separately. Sales with neither attribute are labeled "no plan disclosed".

Full methodology

Former or inactive filers (23)No filing in 18 months; last reported balances, not in any total

Name	Last filed	Last reported balance
Angus Grant	Aug 13, 2024	8,848 shares, last reported balance as of Aug 9, 2024
Vikki Conway	May 15, 2024	No balance on record
Eric Drape	Mar 7, 2024	145,915 shares, last reported balance as of Mar 5, 2024
Sven Dethlefs	Mar 8, 2023	165,381 shares, last reported balance as of Mar 7, 2023
David Stark	Mar 8, 2023	2,974 shares, last reported balance as of Mar 7, 2023
Galia Inbar	Mar 7, 2023	46,011 shares, last reported balance as of Mar 5, 2023
Eli Shani	Mar 7, 2023	54,228 shares, last reported balance as of Mar 5, 2023
Kare Schultz	Nov 2, 2022	1,542,471 shares, last reported balance as of Nov 1, 2022
Jean Halfon	Aug 8, 2022	63,707 shares, last reported balance as of Jun 14, 2022
Nechemia Peres	Aug 8, 2022	58,765 shares, last reported balance as of Jun 14, 2022
Hafrun Fridriksdottir	May 19, 2022	1,387 shares, last reported balance as of May 17, 2022
Andrew Weil	Nov 4, 2021	No balance on record
Abbas Hussain	Jun 16, 2021	No balance on record
Gianfranco Nazzi	Mar 8, 2021	No balance on record
Brendan O'Grady	Mar 8, 2021	14,868 shares, last reported balance as of Mar 5, 2021
Deborah Griffin	Mar 19, 2020	No balance on record
Michael McClellan	Nov 6, 2019	15,898 shares, last reported balance as of Nov 5, 2019
Murray Goldberg	Jun 13, 2019	No balance on record
Carlo de Notaristefani	May 21, 2019	33,589 shares, last reported balance as of May 20, 2019
Iris Codner	Mar 6, 2019	17,996 shares, last reported balance as of Feb 14, 2019
Dan Suesskind	Feb 12, 2018	318,836 shares, last reported balance as of Jan 19, 2018
Galia Maor	Jan 2, 2018	No balance on record
Gabrielle Greene-Sulzberger	Jan 2, 2018	No balance on record

Spotted something wrong on this page? Report an error. We check every report against the SEC filing and list what we fix in the corrections log.